Grant W. Margulieux
Associate
Dr. Grant Margulieux is an associate in the San Diego office of Wilson Sonsini Goodrich & Rosati, where he is a member of the patents and innovations practice.
Prior to joining the firm, Grant completed his doctoral degree at Princeton University. His dissertation focused on the development and synthesis of organometallic catalysts and their uses in the production of pharmaceuticals, fine chemicals, synthetic materials, and alternative fuels. Grant also possesses a strong background in X-ray crystallography and chemical instrumentation.
Experience
Dr. Grant Margulieux is an associate in the San Diego office of Wilson Sonsini Goodrich & Rosati, where he is a member of the patents and innovations practice.
Prior to joining the firm, Grant completed his doctoral degree at Princeton University. His dissertation focused on the development and synthesis of organometallic catalysts and their uses in the production of pharmaceuticals, fine chemicals, synthetic materials, and alternative fuels. Grant also possesses a strong background in X-ray crystallography and chemical instrumentation.
Education
- J.D., University of San Diego School of Law
- Ph.D., Chemistry, Princeton University, 2015
- M.S., Chemistry, University of California, San Diego, 2011
- B.S., Molecular Synthesis, University of California, San Diego, 2009
Admissions
- State Bar of California
- U.S. Patent and Trademark Office
Credentials
Education
- J.D., University of San Diego School of Law
- Ph.D., Chemistry, Princeton University, 2015
- M.S., Chemistry, University of California, San Diego, 2011
- B.S., Molecular Synthesis, University of California, San Diego, 2009
Admissions
- State Bar of California
- U.S. Patent and Trademark Office
Select Publications
- Co-author with M.F. Friedfeld, M. Shelvin, L.C. Campeau, and P.J. Chirik, "Cobalt-Catalyzed Enantioselective Hydrogenation of Minimally Functionalized Alkenes: Isotopic Labeling Provides Insight into the Origin of Stereoselectivity," 138(10) Journal of the American Chemical Society 3314-24, 2016
- Co-author with B.A. Schaefer, B.L. Small, and P.J. Chirik, "Evaluation of Cobalt Complexes Bearing Tridentate Pincer Ligands for Catalytic C-H Borylation," 34(7) Organometallics 1307-20, 2015
- Co-author with C.C. Mokhtarzadeh, A.E. Carpenter, N. Weidemann, C.E. Moore, A.L. Rheingold, and J.S. Figueroa, "Synthesis and Protonation of an Encumbered Iron Tetraisocyanide Dianion," 54(11) Inorganic Chemistry 5579-87, 2015
- Co-author with Z.R. Turner and P.J. Chirik, "Synthesis and Ligand Modification Chemistry of a Molybdenum Dinitrogen Complex: Redox and Chemical Activity of a Bis-(imino)pyridine Ligand," 53(51) Angewandte Chemie International Edition 14211-5, 2014
- Co-author with M.R. Friedfeld, B.A. Schaefer, and P.J. Chirik, "Bis(phosphine)cobalt Dialkyl Complexes for Directed Catalytic Alkene Hydrogenation," 136(38) Journal of the American Chemical Society 13178-81, 2014
- Co-author with S.P. Semproni and P.J. Chirik, "Photochemically Induced Reductive Elimination as a Route to a Zirconocene Complex with a Strongly Activated N2 Ligand," 53(35) Angewandte Chemie International Edition 9189-92, 2014
- Co-author with J.M. Hoyt, M. Shelvin, S.W. Krska, M.T. Tudge, and P.J. Chirik, "Synthesis and Hydrogenation Activity of Iron Dialkyl Complexes with Chiral Bidentate Phosphines," 33(20) Organometallics 5781-90, 2014
- Co-author with R. Yu, J.M. Darmon, C. Milsmann, S.E. Stieber, S. DeBeer, and P.J. Chirik, "Catalytic Hydrogenation Activity and Electronic Structure Determination of Bis(arylimidazol-2-ylidene)pyridine Cobalt Alkyl and Hydride Complexes," 135(35) Journal of the American Chemical Society 13168-84, 2013
- Co-author S.P. Semproni and P.J. Chirik, "Di- and Tetrametallic Hafnocene Oxamidides Prepared from CO-Induced N2 Bond Cleavage and Thermal Rearrangement to Hafnocene Cyanide Derivatives," 31(17) Organometallics 6278-87, 2012
- Co-author with R. Yu, J.D. Darmon, J.M. Hoyt, Z.R. Turner, and P.J. Chirik, "High-Activity Iron Catalysts for Hydrogenation of Hindered, Unfunctionalized Alkenes," 2(8) ACS Catalysis 1760-4, 2012
- Co-author with A.E. Carpenter, M.D. Millard, C.E. Moore, N. Weidemann, A.L. Rheingold, and J.S. Figueroa, "Zwitterionic Stabilization of a Reactive Cobalt Tri-Isocyanide Monoanion by Cation Coordination,"51(37) Angewandte Chemie International Edition 9412-6, 2012
- Co-author with N. Weidemann, C.E. Moore, A.L. Rheingold, and J.S. Figueroa, "Structural Variation in Cobalt Halide Complexes Supported by m-Terphenyl Isocyanides," 364(1) Inorganica Chimica Acta 238-45, 2010
- Co-author with N. Weidemann, D.C. Lacy, C.E. Moore, A.L. Rheingold, and J.S. Figueroa, "Isocyano Analogues of [Co(CO)4]n: A Tetraisocyanide of Cobalt Isolated in Three States of Charge," 132(14) Journal of the American Chemical Society 5033-5, 2010
Insights
Select Publications
- Co-author with M.F. Friedfeld, M. Shelvin, L.C. Campeau, and P.J. Chirik, "Cobalt-Catalyzed Enantioselective Hydrogenation of Minimally Functionalized Alkenes: Isotopic Labeling Provides Insight into the Origin of Stereoselectivity," 138(10) Journal of the American Chemical Society 3314-24, 2016
- Co-author with B.A. Schaefer, B.L. Small, and P.J. Chirik, "Evaluation of Cobalt Complexes Bearing Tridentate Pincer Ligands for Catalytic C-H Borylation," 34(7) Organometallics 1307-20, 2015
- Co-author with C.C. Mokhtarzadeh, A.E. Carpenter, N. Weidemann, C.E. Moore, A.L. Rheingold, and J.S. Figueroa, "Synthesis and Protonation of an Encumbered Iron Tetraisocyanide Dianion," 54(11) Inorganic Chemistry 5579-87, 2015
- Co-author with Z.R. Turner and P.J. Chirik, "Synthesis and Ligand Modification Chemistry of a Molybdenum Dinitrogen Complex: Redox and Chemical Activity of a Bis-(imino)pyridine Ligand," 53(51) Angewandte Chemie International Edition 14211-5, 2014
- Co-author with M.R. Friedfeld, B.A. Schaefer, and P.J. Chirik, "Bis(phosphine)cobalt Dialkyl Complexes for Directed Catalytic Alkene Hydrogenation," 136(38) Journal of the American Chemical Society 13178-81, 2014
- Co-author with S.P. Semproni and P.J. Chirik, "Photochemically Induced Reductive Elimination as a Route to a Zirconocene Complex with a Strongly Activated N2 Ligand," 53(35) Angewandte Chemie International Edition 9189-92, 2014
- Co-author with J.M. Hoyt, M. Shelvin, S.W. Krska, M.T. Tudge, and P.J. Chirik, "Synthesis and Hydrogenation Activity of Iron Dialkyl Complexes with Chiral Bidentate Phosphines," 33(20) Organometallics 5781-90, 2014
- Co-author with R. Yu, J.M. Darmon, C. Milsmann, S.E. Stieber, S. DeBeer, and P.J. Chirik, "Catalytic Hydrogenation Activity and Electronic Structure Determination of Bis(arylimidazol-2-ylidene)pyridine Cobalt Alkyl and Hydride Complexes," 135(35) Journal of the American Chemical Society 13168-84, 2013
- Co-author S.P. Semproni and P.J. Chirik, "Di- and Tetrametallic Hafnocene Oxamidides Prepared from CO-Induced N2 Bond Cleavage and Thermal Rearrangement to Hafnocene Cyanide Derivatives," 31(17) Organometallics 6278-87, 2012
- Co-author with R. Yu, J.D. Darmon, J.M. Hoyt, Z.R. Turner, and P.J. Chirik, "High-Activity Iron Catalysts for Hydrogenation of Hindered, Unfunctionalized Alkenes," 2(8) ACS Catalysis 1760-4, 2012
- Co-author with A.E. Carpenter, M.D. Millard, C.E. Moore, N. Weidemann, A.L. Rheingold, and J.S. Figueroa, "Zwitterionic Stabilization of a Reactive Cobalt Tri-Isocyanide Monoanion by Cation Coordination,"51(37) Angewandte Chemie International Edition 9412-6, 2012
- Co-author with N. Weidemann, C.E. Moore, A.L. Rheingold, and J.S. Figueroa, "Structural Variation in Cobalt Halide Complexes Supported by m-Terphenyl Isocyanides," 364(1) Inorganica Chimica Acta 238-45, 2010
- Co-author with N. Weidemann, D.C. Lacy, C.E. Moore, A.L. Rheingold, and J.S. Figueroa, "Isocyano Analogues of [Co(CO)4]n: A Tetraisocyanide of Cobalt Isolated in Three States of Charge," 132(14) Journal of the American Chemical Society 5033-5, 2010
Recent Insights
Client Highlights
Wilson Sonsini Advises Iambic Therapeutics on $50 Million Series B Extension, Bringing Total Series B Funding to Over $150 Million
On June 18, 2024, Iambic Therapeutics (Iambic), a clinical-stage biotechnology company developing novel therapeutics from its unique generative AI discovery platform, announced the closing of an oversubscribed $50 million extension, bringing the total Series B funding to over $150 million. The Series B extension was led by new investors Mubadala Capital and Exor Ventures, and existing investors Abingworth, Illumina Ventures, Nexus Venture Partners, Coatue, and Tao Capital Partners. Wilson Sonsini Goodrich & Rosati advised Iambic on the transaction.
Learn More
Client Highlights
Wilson Sonsini Advises Halia Therapeutics on $30 Million Series C Financing
On January 31, 2024, Utah-based Halia Therapeutics, a clinical-stage biopharmaceutical company pioneering a novel class of small molecule medications designed to combat inflammation, announced the completion of a $30 million Series C financing. The financing was led by Todd Pedersen, with continued participation from existing investors. Wilson Sonsini Goodrich & Rosati represented Halia Therapeutics in the transaction.
Learn More
- Privacy Policy
- Terms of Use
- Accessibility
Copyright © 2024 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.